Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-18
2009-02-10
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S393000
Reexamination Certificate
active
07488730
ABSTRACT:
A series of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides was prepared and their affinity for serotonin 5-HT7, 5-HT1A, and 5-HT2Areceptors was measured using in vitro binding assays. In relation to 5-HT7receptor affinity, receptor binding studies indicated that: (i) the optimal alkyl chain length was five methylenes; (ii) an unsubstituted 1,2,3,4-tetrahydronaphthalenyl nucleus was selected for further substitutions; and (iii) the substitution pattern of the aryl ring linked to the piperazine ring played a significant role. Several compound with high affinity for 5-HT7receptors were identified. Among them, 4-(2-methoxyphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (28), 4-(2-acetylphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (34), 4-(2-methylthiophenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (44), 4-(2-hydroxyphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (46), 4-(2-methylphenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (49) were assayed for the 5-HT7receptor mediated relaxation of substance P-induced guinea-pig ileum contraction. Compounds 28, 44, and 49 behaved as full agonists, compound 34 as a partial agonist, whereas derivative 46 acted as an antagonist.
REFERENCES:
Leopoldo et al. J. Med. Chem. vol. 47, p.6616-6624 (Nov. 19, 2004).
Perrone et al. J.Med. Chem. vol.42, p.490-496 (1999).
Roth et al. “The Role of Serotonin in Schizophrenia”. Available at http://www.acnp.org/g4/GN401000117/CH115.html, 2000.
Terron, European Journal of Pharmacology,vol.439, p.1-11 (2002).
Berardi Francesco
Colabufo Nicola Antonio
Contino Marialessandra
Lacivita Enza
Leopoldo Marcello
Bernhardt Emily
Beusse Wolter Sanks Mora & Maire
Universita Degli Studi Di Bari
Van Dyke Timothy H.
LandOfFree
N -(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N -(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N -(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112397